ICUI vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

ICUI

39.1
AI Score
VS
XRAY Wins

XRAY

57.2
AI Score

Investment Advisor Scores

ICUI

39score
Recommendation
SELL

XRAY

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ICUI XRAY Winner
Forward P/E 21.3675 7.4627 XRAY
PEG Ratio 0.1007 0.746 ICUI
Revenue Growth 0.5% -4.1% ICUI
Earnings Growth -46.9% 15.2% XRAY
Tradestie Score 39.1/100 57.2/100 XRAY
Profit Margin 1.4% -15.0% ICUI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD XRAY

Relative Price Performance (Last 90 Days)

ICUI 1M: +19.1% · 3M: +39.2% XRAY 1M: -14.2% · 3M: +10.0%

Current Technical Phase

ICUI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.4% over 20 days), RSI 64

RSI (14): 63.8 · Price: $182.84

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

Fundamentals Snapshot

Metric ICUI XRAY
Market Cap
Forward P/E 19.0 7.2
Trailing P/E 156.0
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.4% 0.5%
Operating Margin 0.1% 0.1%
EPS 1.17 -2.71
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.